Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia

Cancer Res. 2003 Apr 1;63(7):1596-601.

Abstract

Cultures of human mammary epithelial cells (HMECs) contain a subpopulation of variant cells with the capacity to propagate beyond an in vitro proliferation barrier. These variant HMECs, which contain hypermethylated and silenced p16(INK4a) (p16) promoters, eventually accumulate multiple chromosomal changes, many of which are similar to those detected in premalignant and malignant lesions of breast cancer. To determine the origin of these variant HMECs in culture, we used Luria-Delbrück fluctuation analysis and found that variant HMECs exist within the population before the proliferation barrier, thereby raising the possibility that variant HMECs exist in vivo before cultivation. To test this hypothesis, we examined mammary tissue from normal women for evidence of p16 promoter hypermethylation. Here we show that epithelial cells with methylation of p16 promoter sequences occur in focal patches of histologically normal mammary tissue of a substantial fraction of healthy, cancer-free women.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Breast / cytology
  • Breast / metabolism
  • Breast / physiology*
  • Cells, Cultured
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • DNA Methylation*
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism
  • Epithelial Cells / physiology
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Promoter Regions, Genetic

Substances

  • Cyclin-Dependent Kinase Inhibitor p16